Par-4 prevents breast cancer recurrence

por Hebbar, Nikhil, Shrestha-Bhattarai, Tripti, Rangnekar, Vivek M
Publicado 2013

AKT mutant allele-specific activation dictates pharmacologic sensitivities

por Shrestha Bhattarai, Tripti, Shamu, Tambudzai, Gorelick, Alexander N., Chang, Matthew T., Chakravarty, Debyani, Gavrila, Elena I., Donoghue, Mark T. A., Gao, JianJong, Patel, Swati, Gao, Sizhi Paul, Reynolds, Margaret H., Phillips, Sarah M., Soumerai, Tara, Abida, Wassim, Hyman, David M., Schram, Alison M., Solit, David B., Smyth, Lillian M., Taylor, Barry S.
Publicado 2022

Tumor Suppressor Par-4 Regulates Complement Factor C3 and Obesity

por Araujo, Nathalia, Sledziona, James, Noothi, Sunil K., Burikhanov, Ravshan, Hebbar, Nikhil, Ganguly, Saptadwipa, Shrestha-Bhattarai, Tripti, Zhu, Beibei, Katz, Wendy S., Zhang, Yi, Taylor, Barry S., Liu, Jinze, Chen, Li, Weiss, Heidi L., He, Daheng, Wang, Chi, Morris, Andrew J., Cassis, Lisa A., Nikolova-Karakashian, Mariana, Nagareddy, Prabhakar R., Melander, Olle, Evers, B. Mark, Kern, Philip A., Rangnekar, Vivek M.
Publicado 2022